Home > Insider Trading > Filing (0001062993-21-010826)

Filing Details

Accession Number:: 0001062993-21-010826
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-11-15 10:55:24
Reporting Period:: 2021-11-11

Accepted Time:: 2021-11-15 10:55:24
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
12208	Bio-Rad Laboratories Inc.	BIO BIOB	Laboratory Analytical Instruments (3826)	941381833

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1717996	Annette Tumolo	C/O Bio-Rad Laboratories, Inc. 1000 Alfred Nobel Drive Hercules CA 94547	Executive Vice President	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Bio-Rad A Common Stock	Acquisiton	2021-11-11	613	$333.34	5,206	No	4	M	Direct
Bio-Rad A Common Stock	Acquisiton	2021-11-11	500	$333.34	5,706	No	4	M	Direct
Bio-Rad A Common Stock	Acquisiton	2021-11-11	433	$524.30	6,139	No	4	M	Direct
Bio-Rad A Common Stock	Disposition	2021-11-11	433	$748.08	5,706	No	4	S	Direct
Bio-Rad A Common Stock	Disposition	2021-11-11	613	$748.84	5,093	No	4	S	Direct
Bio-Rad A Common Stock	Disposition	2021-11-11	500	$750.00	4,593	No	4	S	Direct
Bio-Rad A Common Stock	Acquisiton	2021-11-12	600	$159.32	5,193	No	4	M	Direct
Bio-Rad A Common Stock	Acquisiton	2021-11-12	2,400	$215.98	7,593	No	4	M	Direct
Bio-Rad A Common Stock	Acquisiton	2021-11-12	1,800	$326.15	9,393	No	4	M	Direct
Bio-Rad A Common Stock	Disposition	2021-11-12	4,800	$750.05	4,593	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Bio-Rad A Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2021-11-11	433	$0.00	433	$524.30
Bio-Rad A Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2021-11-11	1,113	$0.00	1,113	$333.34
Bio-Rad A Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2021-11-12	1,800	$0.00	1,800	$326.15
Bio-Rad A Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2021-11-12	2,400	$0.00	2,400	$215.98
Bio-Rad A Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2021-11-12	600	$0.00	600	$159.32

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
1,300	2030-09-02	No	4	M	Direct
1,671	2029-09-03	No	4	M	Direct
1,200	2028-09-04	No	4	M	Direct
600	2027-09-05	No	4	M	Direct
0	2026-09-07	No	4	M	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $750.00 to $750.61, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The option, representing a right to purchase a total of 1,733 shares, became exercisable in four equal annual installments beginning on September 2, 2021, which was the first anniversary of the date on which the option was granted.
The option, representing a right to purchase a total of 2,784 shares, became exercisable in five equal annual installments beginning on September 3, 2020, which was the first anniversary of the date on which the option was granted.
The option, representing a right to purchase a total of 3,000 shares, became exercisable in five equal annual installments beginning on September 4, 2019, which was the first anniversary of the date on which the option was granted.
The option, representing a right to purchase a total of 3,000 shares, became exercisable in five equal annual installments beginning on September 5, 2018, which was the first anniversary of the date on which the option was granted.
The option, representing a right to purchase a total of 3,000 shares, became exercisable in five equal annual installments beginning on September 7, 2017, which was the first anniversary of the date on which the option was granted.